Enoxolone

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Enoximone 是一种选择性磷酸二酯酶抑制剂，具有血管舒张和正性肌力活性，不会引起心肌耗氧量的变化。

Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.

——

——

Arthrodont | Biosone | Enoxolone | α-Glycyrrhetinic Acid? | GM 1658 | NSC 35347 | PO 12 | STX 352

Metabolic Enzyme/Protease

Dehydrogenase

DHO

Other Indications

——

471-53-4

470.68

C30H46O4

>98% (HPLC)

DMSO: 94 mg/mL (199.71 mM)

CC(C)([C@](CC[C@@]([C@@]1(CC[C@]2(CC[C@](C(O)=O)(C[C@]2(C1=C3)[H])C)C)C)4C)5[H])[C@@H](O)CC[C@]5(C)[C@@]4([H])C3=O

(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid

(-20℃)

With Ice Pack

≥ 2 years